BRAF V600 and non-V600 mutations across distinct tumor types.

e24297Background: BRAF gene mutation, especially V600E, was frequently mutated in melanoma, vemurafenib and dabrafenib has already been approved in melanoma and NSCLC. But the landscape of BRAF non...